The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.
GlobalData on MSN
FDA to review Eisai’s Leqembi Iqlik sBLA for Alzheimer’s
The FDA has set a Prescription Drug User Fee Act action date for 24 May 2026.
In short, everything that makes Clawdbot unique and helpful also makes it potentially risky. Generally, AI processes that ...
The Chosun Ilbo on MSN
Battery rally drives KOSDAQ milestone; EcoPro BM nears Alteogen's market cap
The KOSDAQ index recently surpassed the 1,000-point mark, drawing market attention, while competition between Alteogen and ...
7hon MSN
Considering Testosterone Therapy? We Break Down the Entire Process From Diagnosis to Monitoring
Learn how testosterone therapy works step by step, including diagnosis, treatment options, monitoring, and potential risks for men.
Over 200 stray dogs were reportedly killed in Telangana, a complaint on the act in December was lodged in January ...
On January 28, the Supreme Court will hear representations from all States and Union Territories on the stray dog issue ...
Two days of intensive oatmeal intake lowered LDL cholesterol and shifted gut bacteria, pointing to a rapid nutrition strategy for lipid control.
Hull City and their Championship rivals are now well into the final week of the January transfer window, with things starting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results